Fingolimod (FTY720) inhibits neuroinflammation and attenuates spontaneous convulsions in lithium-pilocarpine induced status epilepticus in rat model.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Pharmacology, Biochemistry and Behavior

• Publication date

  2012-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.pbb.2012.08.025PMID 22960129
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The PPARγ agonist rosiglitazone prevents cognitive impairment by inhibiting astrocyte activation and oxidative stress following pilocarpine-induced status epilepticus

  2012cited by this paper
• The role of inflammation in epilepsy

  2011cited by this paper
• Fingolimod modulates microglial activation to augment markers of remyelination

  2011cited by this paper
• Fingolimod provides long‐term protection in rodent models of cerebral ischemia

  2011influential reference
• Brain Infiltration of Leukocytes Contributes to the Pathophysiology of Temporal Lobe Epilepsy

  2011cited by this paper
• Differential responses of human microglia and blood-derived myeloid cells to FTY720.

  2011cited by this paper
• S1P Is Associated with Protection in Human and Experimental Cerebral Malaria

  2011cited by this paper
• Role of glia in epilepsy-associated neuropathology, neuroinflammation and neurogenesis.

  2011cited by this paper
• Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis

  2011influential reference
• Interleukin-1β Biosynthesis Inhibition Reduces Acute Seizures and Drug Resistant Chronic Epileptic Activity in Mice

  2011cited by this paper
• Administration of Simvastatin after Kainic Acid-Induced Status Epilepticus Restrains Chronic Temporal Lobe Epilepsy

  2011cited by this paper
• Inflammation and prevention of epileptogenesis.

  2011cited by this paper
• Sphingosine 1‐phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions

  2010cited by this paper
• Neuron-astrocyte communication and synaptic plasticity.

  2010cited by this paper
• The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy.

  2010cited by this paper
• Fingolimod is a potential novel therapy for multiple sclerosis

  2010cited by this paper
• Activation of Sphingosine 1-Phosphate Receptor-1 by FTY720 Is Neuroprotective After Ischemic Stroke in Rats

  2010cited by this paper
• Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis

  2010cited by this paper
• Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures

  2010cited by this paper
• FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation

  2010cited by this paper
• Roles of astrocytes and microglia in seizure‐induced aberrant neurogenesis in the hippocampus of adult rats

  2009influential reference
• FTY720 Reduces Inflammation and Promotes Functional Recovery after Spinal Cord Injury

  2009cited by this paper
• Effects of SC58236, a selective COX-2 inhibitor, on epileptogenesis and spontaneous seizures in a rat model for temporal lobe epilepsy.

  2009influential reference
• The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia.

  2009cited by this paper
• FTY720 Rescue Therapy in the Dark Agouti Rat Model of Experimental Autoimmune Encephalomyelitis: Expression of Central Nervous System Genes and Reversal of Blood‐Brain‐Barrier Damage

  2009cited by this paper
• Interleukin Converting Enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1beta production.

  2008influential reference
• Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy.

  2008influential reference
• Experimentally induced various inflammatory models and seizure: understanding the role of cytokine in rat.

  2008cited by this paper
• Role of Cytokines During Epileptogenesis and in the Transition from the Interictal to the Ictal State in the Epileptic Mutant EL Mouse

  2008cited by this paper
• Rapid astrocyte and microglial activation following pilocarpine‐induced seizures in rats

  2008cited by this paper
• Pentoxifylline ameliorates lithium-pilocarpine induced status epilepticus in young rats.

  2008cited by this paper
• Central nervous system-directed effects of FTY720 (fingolimod).

  2008cited by this paper
• Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis.

  2008cited by this paper
• Erythropoietin reduces epileptogenic processes following status epilepticus

  2008cited by this paper
• FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis.

  2007cited by this paper
• Brain Penetration of the Oral Immunomodulatory Drug FTY720 and Its Phosphorylation in the Central Nervous System during Experimental Autoimmune Encephalomyelitis: Consequences for Mode of Action in Multiple Sclerosis

  2007cited by this paper
• Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors.

  2007cited by this paper
• Glial Activation Links Early‐Life Seizures and Long‐Term Neurologic Dysfunction: Evidence Using a Small Molecule Inhibitor of Proinflammatory Cytokine Upregulation

  2007cited by this paper
• New Roles for Interleukin-1 Beta in the Mechanisms of Epilepsy

  2007cited by this paper
• Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

  2007cited by this paper
• Interleukin‐1 System in CNS Stress

  2007cited by this paper
• Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy.

  2007cited by this paper
• Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus.

  2006cited by this paper
• Epileptogenic roles of astroglial death and regeneration in the dentate gyrus of experimental temporal lobe epilepsy

  2006cited by this paper
• Epileptogenesis-related genes revisited.

  2006influential reference
• The Blood–Brain Barrier and Epilepsy

  2006cited by this paper
• Repair of the Injured Adult Hippocampus through Graft-Mediated Modulation of the Plasticity of the Dentate Gyrus in a Rat Model of Temporal Lobe Epilepsy

  2005cited by this paper
• An astrocytic basis of epilepsy

  2005cited by this paper
• Differential Regulation of AMPA Receptor and GABA Receptor Trafficking by Tumor Necrosis Factor-α

  2005cited by this paper
• Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha.

  2005cited by this paper
• Human neural stem cell transplantation reduces spontaneous recurrent seizures following pilocarpine-induced status epilepticus in adult rats.

  2004cited by this paper
• Temporal patterns of the cerebral inflammatory response in the rat lithium-pilocarpine model of temporal lobe epilepsy.

  2004cited by this paper
• Continuous cytosine‐b‐D‐arabinofuranoside infusion reduces ectopic granule cells in adult rat hippocampus with attenuation of spontaneous recurrent seizures following pilocarpine‐induced status epilepticus

  2004cited by this paper
• Microglial activation state and lysophospholipid acid receptor expression

  2003cited by this paper
• Interleukin-1β Enhances NMDA Receptor-Mediated Intracellular Calcium Increase through Activation of the Src Family of Kinases

  2003cited by this paper
• Electrophysiological evidence of monosynaptic excitatory transmission between granule cells after seizure-induced mossy fiber sprouting.

  2003cited by this paper
• Ultrastructural features of sprouted mossy fiber synapses in kindled and kainic acid‐treated rats

  2003cited by this paper
• The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors*

  2002cited by this paper
• Is mossy fiber sprouting present at the time of the first spontaneous seizures in rat experimental temporal lobe epilepsy?

  2001cited by this paper
• Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice.

  2000cited by this paper
• Functional and Molecular Properties of Human Astrocytes in Acute Hippocampal Slices Obtained from Patients with Temporal Lobe Epilepsy

  2000cited by this paper
• Fluoro-Jade: Novel Fluorochromes for Detecting Toxicant-Induced Neuronal Degeneration

  2000cited by this paper
• Septotemporal variation of the supragranular projection of the mossy fiber pathway in the dentate gyrus of normal and kindled rats

  1992cited by this paper
• Blood.

  1989cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• Modification of seizure activity by electrical stimulation. 3. Mechanisms.

  1972cited by this paper
• Modification of seizure activity by electrical stimulation. II. Motor seizure.

  1972cited by this paper

• Metabolomics-driven exploration of sphingosine 1-phosphate mechanisms in refractory epilepsy.

  2025cites this paper
• Pathophysiology of Status Epilepticus Revisited

  2025cites this paper
• Fingolimod Suppresses NLRP3 Inflammasome Activation and Alleviates Oxidative Stress in Traumatic Brain Injury-Induced Acute Lung Injury

  2025cites this paper
• The multiple hit model of infantile and epileptic spasms: The 2025 update.

  2025cites this paper
• Astrocyte S1P1 regulates mitochondrial autophagy in inflammation and neuronal injury after epilepsy.

  2025cites this paper
• The sphingosine‐1‐phosphate signaling pathway (sphingosine‐1‐phosphate and its receptor, sphingosine kinase) and epilepsy

  2024cites this paper
• TMS and EEG Pharmacodynamic Effects of a Selective Sphingosine‐1‐Phosphate Subtype 1 Receptor Agonist on Cortical Excitability in Healthy Subjects

  2024cites this paper
• Therapeutic Potential of Fingolimod on Psychological Symptoms and Cognitive Function in Neuropsychiatric and Neurological Disorders

  2024cites this paper
• SEW2871 reduces seizures via the sphingosine 1‐phosphate receptor‐1 pathway in the pentylenetetrazol and phenobarbitone kindling model of drug‐refractory epilepsy

  2024cites this paper
• MyD88‐mediated signaling is critical for the generation of seizure responses and cognitive impairment in a model of anti‐N‐methyl‐D‐aspartate receptor encephalitis

  2024cites this paper
• The Current Landscape in the Development of Small-molecule Modulators Targeting Sphingosine-1-phosphate Receptors to Treat Neurodegenerative Diseases.

  2024cites this paper
• Exploring the molecular targets of fingolimod and siponimod for treating the impaired cognition of schizophrenia using network pharmacology and molecular docking

  2024cites this paper
• Fingolimod administration following hypoxia induced neonatal seizure can restore impaired long-term potentiation and memory performance in adult rats.

  2023cites this paper
• Fingolimod mitigates memory loss in a mouse model of Gulf War Illness amid decreasing the activation of microglia, protein kinase R, and NFκB.

  2023cites this paper
• Molecular Pharmacology and Novel Potential Therapeutic Applications of Fingolimod

  2022cites this paper
• Molecular Mechanisms in the Genesis of Seizures and Epilepsy Associated With Viral Infection

  2022cites this paper
• Dysregulation of Sphingosine-1-Phosphate (S1P) and S1P Receptor 1 Signaling in the 5xFAD Mouse Model of Alzheimer's Disease.

  2022cites this paper
• Effect of Fingolimod on GABA, TNFa, SOD and glutathione peroxidase (Gsh px) level in PTZ induced generalized tonic clonic epilepsy in rats

  2021cites this paper
• An Overview of the Efficacy and Safety of Ozanimod for the Treatment of Relapsing Multiple Sclerosis

  2021cites this paper
• The antiinflammatory and electrophysiological effects of fingolimod on penicillin-induced rats

  2021cites this paper
• Sleep Disruption Worsens Seizures: Neuroinflammation as a Potential Mechanistic Link

  2021cites this paper
• The Cross Talk between Underlying Mechanisms of Multiple Sclerosis and Epilepsy May Provide New Insights for More Efficient Therapies

  2021cites this paper
• FTY720 administration following hypoxia-induced neonatal seizure reverse cognitive impairments and severity of seizures in male and female adult rats: the role of inflammation.

  2021cites this paper
• Neuroinflammation as a Therapeutic Target for Mitigating the Long-Term Consequences of Acute Organophosphate Intoxication

  2021cites this paper
• Molecular Effects of FDA-Approved Multiple Sclerosis Drugs on Glial Cells and Neurons of the Central Nervous System

  2020influential citation
• Systematic evaluation of rationally chosen multitargeted drug combinations: A combination of low doses of levetiracetam, atorvastatin and ceftriaxone exerts antiepileptogenic effects in a mouse model of acquired epilepsy.

  2020cites this paper
• Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis

  2020cites this paper
• From the Molecular Mechanism to Pre-clinical Results: Anti-epileptic Effects of Fingolimod

  2020cites this paper
• Inflammation and reactive oxygen species as disease modifiers in epilepsy.

  2020cites this paper
• No prevention or cure of epilepsy as yet.

  2020cites this paper
• Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy?

  2020cites this paper
• Modulation of sphingosine-1-phosphate receptor by FTY720 contributes in improvement of hepatic encephalopathy induced by bile duct ligation.

  2019cites this paper
• WAG/Rij rat model: a resource for the pharmacology of epileptogenesis and related neurological/psychiatric comorbidities

  2019cites this paper
• Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases

  2019cites this paper
• FTY720 Inhibits MPP+-Induced Microglial Activation by Affecting NLRP3 Inflammasome Activation

  2019cites this paper
• Network pharmacology for antiepileptogenesis: Tolerability and neuroprotective effects of novel multitargeted combination treatments in nonepileptic vs. post-status epilepticus mice.

  2019cites this paper
• Could α-Synuclein Modulation of Insulin and Dopamine Identify a Novel Link Between Parkinson’s Disease and Diabetes as Well as Potential Therapies?

  2018cites this paper
• Epilepsy

  2018cites this paper
• Anti-epileptogenic and Anti-convulsive Effects of Fingolimod in Experimental Temporal Lobe Epilepsy

  2018cites this paper
• The Sphingosine 1‐Phosphate Analogue FTY720 Alleviates Seizure‐induced Overexpression of P‐Glycoprotein in Rat Hippocampus

  2018cites this paper
• Pharmacology of epileptogenesis and related comorbidities in the WAG/Rij rat model of genetic absence epilepsy.

  2018cites this paper
• Fingolimod phosphate inhibits astrocyte inflammatory activity in mucolipidosis IV

  2018cites this paper
• Investigating Inflammatory Pathways as Therapeutic Targets and Biomarkers using Functional Imaging and Pharmacological Interventions in Epilepsy Models.

  2018influential citation
• TNFα disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice.

  2018cites this paper
• FTY720 attenuates behavioral deficits in a murine model of systemic lupus erythematosus.

  2018cites this paper
• Clinical studies and anti‐inflammatory mechanisms of treatments

  2017cites this paper
• Anticonvulsant effects of antiaris toxicaria aqueous extract: investigation using animal models of temporal lobe epilepsy

  2017cites this paper
• Magnesium sulfate attenuates brain edema by lowering AQP4 expression and inhibits glia‐mediated neuroinflammation in a rodent model of eclampsia

  2017cites this paper
• Identification of Sphingosine 1-Phosphate Receptor Subtype 1 (S1P1) as a Pathogenic Factor in Transient Focal Cerebral Ischemia

  2017cites this paper
• Therapeutic Strategies Under Development Targeting Inflammatory Mechanisms in Amyotrophic Lateral Sclerosis

  2017cites this paper
• Prevention of epilepsy: Should we be avoiding clinical trials?

  2017cites this paper
• Effects of FTY720 on brain neurogenic niches in vitro and after kainic acid-induced injury

  2017cites this paper
• FTY720-derivatives do not induce FTY720-like lymphopenia

  2017cites this paper
• α-Asarone Attenuates Cognitive Deficit in a Pilocarpine-Induced Status Epilepticus Rat Model via a Decrease in the Nuclear Factor-κB Activation and Reduction in Microglia Neuroinflammation

  2017cites this paper
• The Sphingosine 1-Phosphate Signaling Pathway in Epilepsy: A Possible Role for the Immunomodulator Drug Fingolimod in Epilepsy Treatment.

  2017influential citation
• Fingolimod Limits Acute Aβ Neurotoxicity and Promotes Synaptic Versus Extrasynaptic NMDA Receptor Functionality in Hippocampal Neurons

  2017cites this paper
• Modulators of microglial activation and polarization after intracerebral haemorrhage

  2017cites this paper
• FTY720 (fingolimod) regulates key target genes essential for inflammation in microglial cells as defined by high‐resolution mRNA sequencing

  2017cites this paper
• Fingolimod (FTY720) attenuates social deficits, learning and memory impairments, neuronal loss and neuroinflammation in the rat model of autism

  2017cites this paper
• Fingolimod enhances myelin repair of hippocampus in pentylenetetrazol‐induced kindling model

  2017cites this paper
• Fingolimod Exerts only Temporary Antiepileptogenic Effects but Longer-Lasting Positive Effects on Behavior in the WAG/Rij Rat Absence Epilepsy Model

  2017influential citation
• Sphingosine‐1‐phosphate receptor therapies: Advances in clinical trials for CNS‐related diseases

  2017cites this paper
• Identifying key regulators of the immune/inflammatory response for developing anticonvulsive and antiepileptogenic approaches

  2017cites this paper
• Chronic Trigeminal Nerve Stimulation Protects Against Seizures, Cognitive Impairments, Hippocampal Apoptosis, and Inflammatory Responses in Epileptic Rats

  2016cites this paper
• Preclinical Metabolism, Pharmacokinetics and In Vivo Analysis of New Blood-Brain-Barrier Penetrant Fingolimod Analogues: FTY720-C2 and FTY720-Mitoxy

  2016cites this paper
• Interactions between Stress-induced Inflammation, Glycogen Synthase Kinase 3 (GSK3), and Depression

  2016cites this paper
• Preventing epileptogenesis: A realistic goal?

  2016cites this paper
• Sphingosine 1-phosphate signaling at the blood-brain barrier.

  2015cites this paper
• GluN2B-containing NMDA receptors are upregulated in plasma membranes by the sphingosine-1-phosphate analog FTY720P.

  2015cites this paper
• FTY720 attenuates excitotoxicity and neuroinflammation

  2015cites this paper
• Fingolimod shows antiepileptogenic and anti anxiety / depressive effects in Wag / Rij rats , a well established model of absence epilepsy and neuropsychiatric comorbidities

  2015cites this paper
• Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application

  2015cites this paper
• Past and Present Definitions of Epileptogenesis and Its Biomarkers

  2014cites this paper
• Effets métaboliques et comportementaux à long terme de l'administration précoce de carisbamate dans le modèle d'épilepsie "lithium-pilocarpine" chez le rat

  2014cites this paper
• Gender issues in antiepileptogenic treatments.

  2014cites this paper
• Fingolimod for the treatment of neurological diseases—state of play and future perspectives

  2014cites this paper
• Role of histaminergic system in blood-brain barrier dysfunction associated with neurological disorders.

  2014cites this paper
• Alteration of Hippocampal Cytokines and Astrocyte Morphology Observed in Rats 24 Hour after Fluid Percussion Injury

  2014cites this paper
• Efectos del fingolimod en el sistema nervioso central

  2014cites this paper
• Neuropeptide Y protects cerebral cortical neurons by regulating microglial immune function

  2014cites this paper
• Alteration of Hippocampal Cytokines and Astrocyte Morphology Observed in Rats 24 Hour after Fluid Percussion

  2014cites this paper
• Central effects of fingolimod.

  2014cites this paper
• Novel FTY720-Based Compounds Stimulate Neurotrophin Expression and Phosphatase Activity in Dopaminergic Cells.

  2014cites this paper
• Fingolimod affects gene expression profile associated with LPS-induced memory impairment

  2014cites this paper
• Fingolimod exerts neuroprotective effects in a mouse model of intracerebral hemorrhage.

  2014cites this paper
• The Potential of Antiseizure Drugs and Agents that Act on Novel Molecular Targets as Antiepileptogenic Treatments

  2014cites this paper
• Treatment of Status Epilepticus with Ketamine, Are we There yet?

  2013cites this paper
• Intra and extracellular functions of sphingosine-1-phosphate in sterile inflammation

  2013cites this paper
• Novel Therapeutic Approaches to Multiple Sclerosis: Neuroprotective Drugs for Relapsing-Remitting Multiple Sclerosis

  2013cites this paper
• What can we learn from animal models of convulsive status epilepticus?

  2013cites this paper
• Fingolimod phosphate promotes the neuroprotective effects of microglia.

  2013cites this paper
• Pharmacological blockade of IL-1β/IL-1 receptor type 1 axis during epileptogenesis provides neuroprotection in two rat models of temporal lobe epilepsy.

  2013cites this paper
• Author's Personal Copy Behavioural Brain Research Neurorestorative Effect of Fty720 in a Rat Model of Alzheimer's Disease: Comparison with Memantine

  year unknowncites this paper